1–1 of 1 result for Yuxi Zheng
Evaluating Clinical Signs of Regression in Eyes Treated With Intravitreal Bevacizumab for Type 1 Retinopathy of Prematurity
Yuxi Zheng, MD
Annual Meeting Talks
2025